Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 5, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Hypsibius exemplaris: a tardigrade as an emerging model for mitochondrial enzyme analysis

THSTI BTech & MSc Life Science Project Associate Recruitment

AIIMS New Delhi Non-Medical Life Science & Microbiology Scientist

Hypsibius exemplaris: a tardigrade as an emerging model for mitochondrial enzyme analysis
  • BiotechToday
  • World

Hypsibius exemplaris: a tardigrade as an emerging model for mitochondrial enzyme analysis

bioxone December 16, 2020December 16, 2020

Ayooshi Mitra, Amity University, Kolkata

Mitochondrial alternative oxidase (AOX) is an enzyme that forms an integral part of the electron transport chain (ETS) in mitochondria. This enzyme is present in the mitochondria of many invertebrates. The expression of AOX in human mitochondria is regarded as a potential therapeutic strategy, regardless of the reason for the occurrence of the enzyme in animal mitochondria. To date, quite some data is available due to heterologous AOX expression in animal cells, but there is no or very little data available on natively expressed AOX. 

The research contributes significantly to the application of animals that express AOX natively. As a model for AOX activity analysis, the study considered the tardigrade, exemplaris. It was observed that in the presence of an AOX inhibitor, the tolerance of Hypsibius exemplaris to blockage of the mitochondrial respiratory chain (MRC) complexes was decreased. It was also noted that the inhibitor-sensitive respiration enabled tardigrade respiration under this blockage condition. In addition, although the detection of AOX at the protein level and the pronounced oxygraphic recording of its activity required the blockage of the MRC complex, the data obtained showed that AOX contributed to animal functioning. The researchers showed that AOX activity in tardigrades can be supervised by measuring the whole-body respiration of the intact specimen. In addition, the impact of MRC complex IV blockage on AOX expression and AOX inhibition in the absence of blockage on the functioning of animals could also be monitored. 

Therefore, Hypsibius exemplaris is prospected to be a useful model organism for the study of the natively expressed mitochondrial alternative oxidase (AOX) enzyme as a whole-animal model. These analyses will help in estimating the impact of the AOX enzyme on animal behavior and the functioning of mitochondria under normal conditions as well as when subjected to external stress factors.

Also read: THE ROLE OF LEWY BODIES IN PARKINSON’S DISEASE

Reference:

  1. Grobys D., Roszkowska M., Kaczmarek Ł., Jarmuszkiewicz W., Karachitos A.,  Kmita H. (2020). The Tardigrade Hypsibius Exemplaris as an Emerging Model to Study the Mitochondrial Alternative Oxidase at Animal Organismal Level. bioRxiv.https://www.biorxiv.org/content/10.1101/2020.12.09.417485v1.full
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged AOX Enzyme Hypsibius inhibitor invertebrates Mitochondria mitochondrial alternative oxidase MRC complex Tardigrade therapeutics whole-animal model

One thought on “Hypsibius exemplaris: a tardigrade as an emerging model for mitochondrial enzyme analysis”

  1. Pingback: Nuclei of each muscle fiber differ in terms of gene activity - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

AIIMS New Delhi Non-Medical Life Science & Microbiology Scientist

bioxone December 16, 2020

-Shristi Sharma, Team bioXone AIIMS Non Medical Scientist Jobs For Life Science/Microbiology. Scientist C (Non Medical) Jobs for PhD Life Science/Microbiology applicants. Interested and eligible applicants can check out all of the details on the same below: Name of the Post: Scientist C (Non Medical) No. of Posts: 01 Name of the Project: “Clinical and […]

Related Post

  • BiotechToday
  • World

New Acyl CoA synthetase 4 inhibitor reduces breast and prostate tumour growth

bioxone October 19, 2020October 19, 2020

Rohit Bhattacharjee, Amity University Kolkata Acyl CoA synthetase 4 (ACSL4) is an isoenzyme of the fatty acid ligase-coenzyme A family that takes part in arachidonic acid metabolism and steroidogenesis. ACSL4 is involved in tumour aggressiveness in breast and prostate tumours through various signal transduction pathways regulation. A well-validated ACSL4 inhibitor, however, has not been reported […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Studying p38-MAPK – A signaling pathway in mice embryos

BioTech Today July 17, 2021July 17, 2021

Agrima Bhatt, Rajasthan University In previous studies, p38-MAPK was identified as a regulator for blastocyst ICM fate in the mouse embryo. Today, scientists are trying to find out the functional role of the DDX21 protein. For the understanding of this complex pathway, let’s first deep dive into the embryo and its development stages. Fusion of […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Prediction model for Thyrotoxic Atrial Fibrillation

bioxone July 13, 2021July 13, 2021

Husna, Amity University Kolkata What is Thyrotoxic Atrial Fibrillation (TAF)?  Hyperthyroidism is a medical condition in which there is an overactivity of the thyroid gland which leads to rapid heartbeat and excessive production of thyroxine hormone in the body. The most common severe complication of hyperthyroidism in an individual is Thyrotoxic Atrial fibrillation (TAF). Atrial fibrillation […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy